Botox may be used to treat muscle spasticity in children ages 2 years and older. The dosage is based on the child’s weight and the location of the injections.

AbbVie is hoping to extend its range of neurotoxin-based pharma and cosmetic products with trenibotulinumtoxinE (TrenibotE), a short-acting successor to its blockbuster Botox brand, that has just ...

Along with Botox, Dysport, Xeomin, and Jeuveau, a neurotoxin called daxibotulinumtoxinA (Daxi), may soon be approved by the U.S. Food and Drug Administration (FDA) for the treatment of glabellar ...